Medical Cannabis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Medical Cannabis stocks.

Medical Cannabis Stocks Recent News

Date Stock Title
Nov 22 CGC What's Happening With Canopy Growth: Is It Time To Buy?
Nov 21 CGC German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Nov 21 ACB German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Nov 21 TLRY German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Nov 21 CGC Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
Nov 21 TLRY Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
Nov 21 TLRY Tilray Brands snapped six straight sessions of losses
Nov 21 TLRY Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes
Nov 21 TLRY Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide
Nov 21 TLRY Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide
Nov 20 TLRY Tilray Brands, Inc. (TLRY) Stock Moves -1.53%: What You Should Know
Nov 20 CGC The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
Nov 20 TLRY Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
Nov 20 CGC Canopy Growth Launches Claybourne Infused Pre-Rolls in Canada
Nov 20 ACB Aurora Cannabis Expands Innovative Recreational Product Portfolio
Nov 20 TLRY Exploring ACNB And 2 More Undervalued Small Caps With Insider Buying In US
Nov 20 TLRY Beverages, Alcohol and Tobacco Stocks Q3 Recap: Benchmarking Tilray Brands (NASDAQ:TLRY)
Nov 19 TLRY Tilray Stock Hits 52-Week Low: A Buying Opportunity or a Warning Sign?
Nov 19 TLRY Q3 Earnings Outperformers: Celsius (NASDAQ:CELH) And The Rest Of The Beverages, Alcohol and Tobacco Stocks
Nov 18 ACB Aurora Cannabis snaps eight straight sessions of losses
Medical Cannabis

Medical cannabis, or medical marijuana, is cannabis and cannabinoids that are recommended by doctors for their patients. The use of cannabis as medicine has not been rigorously tested due to production restrictions and other governmental regulations. Limited evidence suggests that cannabis can reduce nausea and vomiting during chemotherapy, improve appetite in people with HIV/AIDS, and reduce chronic pain and muscle spasms.Short-term use increases the risk of minor and major adverse effects. Common side effects include dizziness, feeling tired, vomiting, and hallucinations. Long-term effects of cannabis are not clear. Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.The Cannabis plant has a history of medicinal use dating back thousands of years in many cultures. A number of medical organizations have requested removal of cannabis from the list of Schedule I controlled substances, followed by regulatory and scientific review. Others oppose its legalization, such as the American Academy of Pediatrics.Medical cannabis can be administered through a variety of methods, including capsules, lozenges, tinctures, dermal patches, oral or dermal sprays, cannabis edibles, and vaporizing or smoking dried buds. Synthetic cannabinoids are available for prescription use in some countries, such as dronabinol and nabilone. Countries that allow the medical use of whole-plant cannabis include Australia, Canada, Chile, Colombia, Germany, Greece, Israel, Italy, the Netherlands, Peru, Poland, Portugal, and Uruguay. In the United States, 33 states and the District of Columbia have legalized cannabis for medical purposes, beginning with the passage of California's Proposition 215 in 1996. Although cannabis remains prohibited for any use at the federal level, the Rohrabacher–Farr amendment was enacted in December 2014, limiting the ability of federal law to be enforced in states where medical cannabis has been legalized.

Browse All Tags